Rarebase, a biotechnology public benefit corporation based in Palo Alto, California, is dedicated to advancing personalized medicine for genetic diseases that lack effective treatments. Operating at the intersection of technology and biology, Rarebase collaborates closely with patient communities to ensure that drug discovery and development are aligned with their shared goals. The company’s Function™ drug […]